Literature DB >> 8617807

Agrin binding to alpha-dystroglycan. Domains of agrin necessary to induce acetylcholine receptor clustering are overlapping but not identical to the alpha-dystroglycan-binding region.

C Hopf1, W Hoch.   

Abstract

The synaptic basal membrane protein agrin initiates the aggregation of acetylcholine receptors at the postsynaptic membrane of the developing neuromuscular junction. Recently, alpha-dystroglycan was found to be a major agrin-binding protein on the muscle cell surface and was therefore considered a candidate agrin receptor. Employing different truncation fragments of agrin, we determined regions of the protein involved in binding to alpha-dystroglycan and to heparin, an inhibitor of alpha-dystroglycan binding. Deletion of a 15-kDa fragment from the C terminus of agrin had no effect on its binding to alpha-dystroglycan from rabbit muscle membranes, even though this deletion completely abolishes its acetylcholine receptor aggregating activity. Conversely, deletion of a central region does not affect agrin's clustering activity, but reduced its affinity for alpha-dystroglycan. Combination of these two deletions resulted in a fragment of approximately 35 kDa that weakly bound to alpha-dystroglycan, but displayed no clustering activity. All of these fragments bound to heparin with high affinity. Thus, alpha-dystroglycan does not show the binding specificity expected for an agrin receptor. Our data suggest the existence of an additional component on the muscle cell surface that generates the observed ligand specificity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617807     DOI: 10.1074/jbc.271.9.5231

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.

Authors:  J F Talts; Z Andac; W Göhring; A Brancaccio; R Timpl
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

Review 2.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

3.  Soluble miniagrin enhances contractile function of engineered skeletal muscle.

Authors:  Weining Bian; Nenad Bursac
Journal:  FASEB J       Date:  2011-11-10       Impact factor: 5.191

4.  Crystal structure of the second LNS/LG domain from neurexin 1alpha: Ca2+ binding and the effects of alternative splicing.

Authors:  Lauren R Sheckler; Lisa Henry; Shuzo Sugita; Thomas C Südhof; Gabby Rudenko
Journal:  J Biol Chem       Date:  2006-06-13       Impact factor: 5.157

5.  MuSK signaling at the neuromuscular junction.

Authors:  Qiang Wang; Bin Zhang; Wen-Cheng Xiong; Lin Mei
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  Differential requirement for MuSK and dystroglycan in generating patterns of neuromuscular innervation.

Authors:  Julie L Lefebvre; Lili Jing; Sara Becaficco; Clara Franzini-Armstrong; Michael Granato
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

7.  The process-inducing activity of transmembrane agrin requires follistatin-like domains.

Authors:  Elmar Porten; Beate Seliger; Verena A Schneider; Stefan Wöll; Daniela Stangel; Rene Ramseger; Stephan Kröger
Journal:  J Biol Chem       Date:  2009-11-25       Impact factor: 5.157

8.  LRP4 serves as a coreceptor of agrin.

Authors:  Bin Zhang; Shiwen Luo; Qiang Wang; Tatsuo Suzuki; Wen C Xiong; Lin Mei
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

9.  A role for the juxtamembrane domain of beta-dystroglycan in agrin-induced acetylcholine receptor clustering.

Authors:  Joanna Kahl; James T Campanelli
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

10.  Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice.

Authors:  Jessica D Gumerson; Carol S Davis; Zhyldyz T Kabaeva; John M Hayes; Susan V Brooks; Daniel E Michele
Journal:  Hum Mol Genet       Date:  2012-12-06       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.